Document is current
Any future updates will be listed below
-
Authors
Lee, Dongheon https://orcid.org/0000-0002-4066-9222
Walls, Mackenzie T. https://orcid.org/0000-0002-1857-987X
Siu, Ka-Hei https://orcid.org/0000-0003-2097-506X
Dai, Yifan https://orcid.org/0000-0002-1009-5790
Xu, Ke
Brangwynne, Clifford P.
Chilkoti, Ashutosh https://orcid.org/0000-0002-1569-2228
Avalos, José L.
You, Lingchong https://orcid.org/0000-0003-3725-4007
-
Funding
Funding for this research was provided by:
United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA9550-20-1-0241, FA9550-20-1-0241, FA9550-20-1-0241, FA9550-20-1-0241)
National Science Foundation (DGE-1656466)
- License Information
-
More Information
Article History
Received: 5 February 2024
Accepted: 12 February 2025
First Online: 12 March 2025
Competing interests
: C.P.B. is a founder of and consultant for Nereid Therapeutics. A patent describing the PpID system is currently pending (US 2023/0295638 A1). The other authors declare no competing interests.
